The serology test has a specificity greater than 99.8% and sensitivity of 100% (14 Days post-PCR confirmation)
The high specificity of the test is crucial to determine reliably if a person has been exposed to the virus and if the patient has developed antibodies
Roche will provide high double-digit millions of tests already in May for countries accepting the CE mark and in the U.S. under Emergency Use Authorization, further ramping up capacities thereafter
The test is available on Roche’s cobas e analysers which are widely available around the world
